HHealth Read More Weight loss drug tirzepatide may lower the risk of diabetic retinopathyFebruary 12, 2026 The popular diabetes and weight loss medication tirzepatide (brand name Mounjaro or Zepbound) may lower the risk of…
HHealth Read More Unprocessed beef does not worsen metabolic health in prediabetesFebruary 2, 2026 A controlled crossover trial finds that short-term consumption of unprocessed beef is on par with poultry for glucose…
HHealth Read More Improving survival in people with severe psychiatric disordersJanuary 26, 2026 An expert editorial suggests that widely used diabetes and obesity drugs may help close the long-standing mortality gap…
HHealth Read More Diabetes drugs linked to slower frailty progression in older adultsDecember 4, 2025 A new study shows that older adults with type 2 diabetes who start treatment with sodium–glucose cotransporter-2 (SGLT-2)…
HHealth Read More WHO releases first guideline on the use of GLP-1 therapies for treating obesityDecember 2, 2025 To address the growing global health challenge of obesity, which affects more than 1 billion people, the World Health…
HHealth Read More Stopping GLP-1 drugs before pregnancy leads to more weight gainDecember 1, 2025 New research shows that women who halt GLP-1 medications near conception face greater gestational weight gain and elevated…
HHealth Read More Searches for “Ozempic face” surge as people look for filler-based solutionsNovember 21, 2025 New search data reveal that as interest in “Ozempic face” surges, people increasingly turn to nonsurgical fillers rather…
HHealth Read More Study compares GLP-1 drug benefits and finds substantial variation in clinical effectsNovember 20, 2025 A new umbrella review reveals how GLP-1 therapies shape cardiovascular, renal, and metabolic outcomes in type 2 diabetes…
HHealth Read More Tirzepatide may only temporarily suppress brain activity involved in “food noise”November 18, 2025 A rare glimpse into the brain activity of a patient with obesity and loss of control eating on…
HHealth Read More Off-label GLP-1 use highlights the cultural pressures driving body anxietiesNovember 14, 2025 A new sociomedical perspective shows how off-label use of GLP-1 drugs for slimness is redefining what counts as…
HHealth Read More Diabetes remission possible with GLP-1 drugs, Italian study confirmsOctober 30, 2025 Real-world data from over 14,000 Italian adults reveal that GLP-1 receptor agonists can induce remission in type 2…
HHealth Read More Exercise can mitigate depression-like behaviors induced by high-fat, high-sugar dietsOctober 21, 2025 Researchers led by Professor Yvonne Nolan at University College Cork have identified specific metabolic pathways through which exercise…